Evidence map›Paper›PMID 25972422›Full record

ArticleJournal of clinical microbiology2015

Assessing Airway Microbiota in Cystic Fibrosis: What More Should Be Done?

John J LiPuma

Abstract readComment
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Vaccines for the Prevention of Melioidosis and Glanders.Current tropical medicine reports · 2017
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. COMPUTATIONAL APPROACHES TO STUDY MICROBES AND MICROBIOMES.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

John J LiPumaDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA jlipuma@umich.edu.

Funding

The lung microbiota in cystic fibrosisRC1HL100809 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LI, JUN, LIPUMA, JOHN J · 2009 to 2010
$999k
NHLBI NIH HHS RC1 HL100809
6 · The paper itself

Abstract

The use of culture-independent methods has deepened our appreciation of the complexity of the bacterial communities that typically reside in the airways of persons with cystic fibrosis (CF). New insights into how changes in the structure of these communities relate to lung disease progression will likely raise expectations for more in-depth microbiologic analysis of CF respiratory specimens. An article in this issue of the Journal of Clinical Microbiology (W. G. Flight, A. Smith, C. Paisey, J. R. Marchesi, M. J. Bull, P. J. Norville, K. J. Mutton, A. K. Webb, R. J. Bright-Thomas, A. M. Jones, and E. Mahenthiralingam, J Clin Microbiol 53:2022-2029, 2015, http://dx.doi.org/10.1128/JCM.00432-15) describes the application of a culture-independent approach to the assessment of CF airway microbiota.

Indexed as

BiodiversityBacteriaCystic FibrosisFemaleHumansMaleMolecular Diagnostic TechniquesPneumonia, BacterialSputum

Identifiers

PMID25972422
PMCPMC4473192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.